Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

The prognostic relevance of tumor hypoxia markers in resected carcinoma of the gallbladder.

Sergeant G, Lerut E, Ectors N, Hendrickx T, Aerts R, Topal B.

Eur J Surg Oncol. 2011 Jan;37(1):80-6. doi: 10.1016/j.ejso.2010.10.007.

PMID:
21109386
2.

Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival.

Varga M, Obrist P, Schneeberger S, Mühlmann G, Felgel-Farnholz C, Fong D, Zitt M, Brunhuber T, Schäfer G, Gastl G, Spizzo G.

Clin Cancer Res. 2004 May 1;10(9):3131-6.

3.

Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.

Kawamoto T, Shoda J, Irimura T, Miyahara N, Furukawa M, Ueda T, Asano T, Kano M, Koike N, Fukao K, Tanaka N, Todoroki T.

Clin Cancer Res. 2001 May;7(5):1333-42.

4.

Estrogen receptor alpha, estrogen receptor beta, and progesterone receptor as possible prognostic factor in radically resected gallbladder carcinoma.

Park JS, Jung WH, Kim JK, Hwang HK, Cho SI, Yoon DS, Chi HS, Kim BR.

J Surg Res. 2009 Mar;152(1):104-10. doi: 10.1016/j.jss.2008.01.032. Epub 2008 Feb 29.

PMID:
18394649
5.
6.

Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer.

Kim WB, Han HJ, Lee HJ, Park SS, Song TJ, Kim HK, Suh SO, Kim YC, Choi SY.

Ann Surg Oncol. 2009 Jan;16(1):23-34. doi: 10.1245/s10434-008-0182-x. Epub 2008 Nov 1.

PMID:
18979138
7.

Syndecan-1 expression in gallbladder cancer and its prognostic significance.

Roh YH, Kim YH, Choi HJ, Lee KE, Roh MS.

Eur Surg Res. 2008;41(2):245-50. doi: 10.1159/000137667. Epub 2008 Jun 10.

PMID:
18544939
8.

RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer.

Oshikiri T, Hida Y, Miyamoto M, Hashida H, Katoh K, Suzuoki M, Nakakubo Y, Hiraoka K, Shinohara T, Itoh T, Kondo S, Katoh H.

Br J Cancer. 2001 Dec 14;85(12):1922-7.

9.

Tumor angiogenesis in gallbladder carcinoma.

Sugawara Y, Makuuchi M, Harihara Y, Noie T, Inoue K, Kubota K, Takayama T.

Hepatogastroenterology. 1999 May-Jun;46(27):1682-6.

PMID:
10430321
10.

Heparanase expression in gallbladder carcinoma and its correlation to prognosis.

Wu W, Pan C, Yu H, Gong H, Wang Y.

J Gastroenterol Hepatol. 2008 Mar;23(3):491-7. Epub 2007 May 24.

PMID:
17524042
11.

Immunohistochemical demonstration of c-Kit protooncogene product in gallbladder cancer.

Tanaka S, Tanaka H, Yamamoto T, Shuto T, Takemura S, Hai S, Sakabe K, Uenishi T, Hirohashi K, Kubo S.

J Hepatobiliary Pancreat Surg. 2006;13(3):228-34.

PMID:
16708300
12.

Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer.

Shiraki M, Odajima T, Ikeda T, Sasaki A, Satoh M, Yamaguchi A, Noguchi M, Nagai I, Hiratsuka H.

Mod Pathol. 2005 Nov;18(11):1482-9.

13.

Expression of epithelial cell adhesion molecule in gallbladder carcinoma and its correlation with clinicopathologic variables.

Prince S, Zeidman A, Dekel Y, Ram E, Koren R.

Am J Clin Pathol. 2008 Mar;129(3):424-9. doi: 10.1309/H8JEEAEB69J3KYND.

14.

[Subserous gallbladder carcinoma: expression of cadherine-catenine complex].

Roa I, Ibacache G, Melo A, Morales E, Villaseca M, Araya J, Roa J, Guzmán P, de Aretxabala X.

Rev Med Chil. 2002 Dec;130(12):1349-57. Spanish.

PMID:
12611235
15.

Skp2 is an independent prognosticator of gallbladder carcinoma among p27(Kip1)-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray.

Li SH, Li CF, Sung MT, Eng HL, Hsiung CY, Huang WW, Lin CN, Yu SC, Huang HY.

Mod Pathol. 2007 Apr;20(4):497-507. Epub 2007 Mar 2.

16.

Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma.

Leone F, Cavalloni G, Pignochino Y, Sarotto I, Ferraris R, Piacibello W, Venesio T, Capussotti L, Risio M, Aglietta M.

Clin Cancer Res. 2006 Mar 15;12(6):1680-5.

17.

A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients.

Thøgersen VB, Sørensen BS, Poulsen SS, Orntoft TF, Wolf H, Nexo E.

Cancer Res. 2001 Aug 15;61(16):6227-33.

18.
19.

Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer.

Roh YH, Kim YH, Choi HJ, Lee KE, Roh MS.

J Hepatobiliary Pancreat Surg. 2009;16(3):315-21. doi: 10.1007/s00534-009-0046-1. Epub 2009 Mar 4.

PMID:
19259612
20.

Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.

Ch'ng S, Low I, Ng D, Brasch H, Sullivan M, Davis P, Tan ST.

Hum Pathol. 2008 Mar;39(3):344-9. Epub 2007 Nov 28.

PMID:
18045646
Items per page

Supplemental Content

Write to the Help Desk